The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake. mRNA vaccine research may be on the chopping block, too.
Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback